Clinical trials for advancing innovative interventions for neurodegenerative diseases
Directly managed European call · HORIZON-HLTH-2027-02-DISEASE-14-two-stage
The title is in English, the language of the official source.
A consortium is required.
The general EU rules ask for at least three independent legal entities from three Member States or associated countries. An SME cannot apply on its own.
- ProgrammeHorizon Europe
- Deadlinecloses in 94 days
- Opening29/10/2026
- Next cut-off17/02/2027
- All cut-offs17/02/2027 · 16/09/2027
- Official type of actionResearch and Innovation Action (RIA)
Framework call: Cluster 1 - Health (Two stage - 2027) · HORIZON-HLTH-2027-02-two-stage
Topics: Brain research, Clinical medicine, Clinical neurology, Clinical research, Clinical trials, Cognition (e.g. learning, memory, emotions, speech), Dementia, Interventional clinical trials, Molecular and cellular neuroscience, Neurobiology, Neurochemistry and neuropharmacology, Neurodegenerative disorde
See the call on the European Commission portal
Other calls under Horizon Europe
Short proposal
Next-Generation QKD Systems
Neutral-Atom Platform Technologies
Trapped-Ion Platform Technologies
All calls under Horizon Europe
We classify each call by its official type of action and the general EU rules: collaborative research and innovation actions ask, as a rule, for three entities from three countries; many coordination and support actions and prizes accept a single entity; the EIC Accelerator is for a single company. Whatever the programme regulation does not set stays under “it depends”. The official text of each call prevails.
Origen de los datos: portal Funding & Tenders de la Comisión Europea (datos abiertos).